Literature DB >> 17954230

LC-MS-MS analysis of neutral eicosanoids.

Philip J Kingsley1, Lawrence J Marnett.   

Abstract

The neutral arachidonic acid derivatives N-arachidonoyl ethanolamine (anandamide or AEA), and 2-arachidonoylglycerol (2-AG) have been identified as endogenous ligands for the cannabinoid receptors. Additionally, these compounds have been identified as substrates of the second isoform of the cyclooxygenase enzyme (COX-2). Through the action of COX-2 and downstream prostaglandin synthases, a diverse family of prostaglandin glycerol esters (PG-Gs) and prostaglandin ethanolamides (PG-EAs) have been identified. Sensitive and reliable analytical methodology is crucial for the continued research on the biological roles of this family of lipids. In this chapter, we discuss methods for analyzing both the precursor endocannabinoids and their PG-like products by LC-MS-MS. Cation coordination provides the ionization, and selected reaction monitoring is successfully employed to provide a method of analysis that is both sensitive and specific.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17954230     DOI: 10.1016/S0076-6879(07)33005-X

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


  14 in total

1.  Inactivation of lipid glyceryl ester metabolism in human THP1 monocytes/macrophages by activated organophosphorus insecticides: role of carboxylesterases 1 and 2.

Authors:  Shuqi Xie; Abdolsamad Borazjani; M Jason Hatfield; Carol C Edwards; Philip M Potter; Matthew K Ross
Journal:  Chem Res Toxicol       Date:  2010-12-20       Impact factor: 3.739

2.  Nutritional omega-3 deficiency abolishes endocannabinoid-mediated neuronal functions.

Authors:  Mathieu Lafourcade; Thomas Larrieu; Susana Mato; Anais Duffaud; Marja Sepers; Isabelle Matias; Veronique De Smedt-Peyrusse; Virginie F Labrousse; Lionel Bretillon; Carlos Matute; Rafael Rodríguez-Puertas; Sophie Layé; Olivier J Manzoni
Journal:  Nat Neurosci       Date:  2011-01-30       Impact factor: 24.884

Review 3.  Quantification of brain endocannabinoid levels: methods, interpretations and pitfalls.

Authors:  Matthew W Buczynski; Loren H Parsons
Journal:  Br J Pharmacol       Date:  2010-06       Impact factor: 8.739

4.  (R)-Profens are substrate-selective inhibitors of endocannabinoid oxygenation by COX-2.

Authors:  Kelsey C Duggan; Daniel J Hermanson; Joel Musee; Jeffery J Prusakiewicz; Jami L Scheib; Bruce D Carter; Surajit Banerjee; J A Oates; Lawrence J Marnett
Journal:  Nat Chem Biol       Date:  2011-11       Impact factor: 15.040

5.  Microsomal omega-hydroxylated metabolites of N-arachidonoyl dopamine are active at recombinant human TRPV1 receptors.

Authors:  N Rimmerman; H B Bradshaw; A Basnet; B Tan; Theodore S Widlanski; J M Walker
Journal:  Prostaglandins Other Lipid Mediat       Date:  2008-09-02       Impact factor: 3.072

Review 6.  Sum of the parts: mass spectrometry-based metabolomics.

Authors:  Stephen B Milne; Thomas P Mathews; David S Myers; Pavlina T Ivanova; H Alex Brown
Journal:  Biochemistry       Date:  2013-03-07       Impact factor: 3.162

Review 7.  Membrane microdomains and metabolic pathways that define anandamide and 2-arachidonyl glycerol biosynthesis and breakdown.

Authors:  Ekaterina A Placzek; Yasuo Okamoto; Natsuo Ueda; Eric L Barker
Journal:  Neuropharmacology       Date:  2008-08-08       Impact factor: 5.250

Review 8.  Druggable Targets in Endocannabinoid Signaling.

Authors:  Ann M Gregus; Matthew W Buczynski
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

Review 9.  Bioinformatics: the next frontier of metabolomics.

Authors:  Caroline H Johnson; Julijana Ivanisevic; H Paul Benton; Gary Siuzdak
Journal:  Anal Chem       Date:  2014-11-20       Impact factor: 6.986

10.  Substrate-selective COX-2 inhibition decreases anxiety via endocannabinoid activation.

Authors:  Daniel J Hermanson; Nolan D Hartley; Joyonna Gamble-George; Naoko Brown; Brian C Shonesy; Phillip J Kingsley; Roger J Colbran; Jeffrey Reese; Lawrence J Marnett; Sachin Patel
Journal:  Nat Neurosci       Date:  2013-08-04       Impact factor: 24.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.